Inflammation in alcohol-associated hepatitis: pathogenesis and therapeutic targets

Novel treatment of acute and acute-on-chronic liver failure: Interleukin-22

Dimethyloxalylglycine suppresses SREBP1c and lipogenic gene expressions in hepatocytes independently of HIF1A

Overexpression of interleukin-8 promotes the progression of fatty liver to nonalcoholic steatohepatitis in mice

Ionically bridged dexamethasone sodium phosphate-zinc-PLGA nanocomplex in alginate microgel for the local treatment of ulcerative colitis

Experimental models of fatty liver diseases: Status and appraisal

Ethanol and its nonoxidative metabolites promote acute liver injury by inducing ER stress, adipocyte death and lipolysis

Heterogeneous population of macrophages in the development of nonalcoholic fatty liver disease

A crystal ball to forecast treatment responsiveness in NAFLD

A bioisosteric approach to the discovery of novel N-aryl-N′-[4-(aryloxy)cyclohexyl]squaramide-based activators of eukaryotic initiation factor 2 alpha (eIF2a) phosphorylation.